Actively Recruiting
Evaluating the Long-term Health Consequences of COVID-19 and Rehabilitation Therapies to Speed Convalescence
Led by VA Office of Research and Development · Updated on 2025-09-18
300
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the long-term effects of COVID-19 on vascular endothelial function and overall health in older Veterans, including those experiencing long-COVID symptoms such as fatigue, weakness, and cognitive difficulties. The study focuses on understanding how oxidative stress and inflammation caused by aging and COVID-19 impact vascular health and recovery, with the goal of improving rehabilitation strategies to reduce health risks and enhance recovery outcomes. Participants will be assigned to one of two groups: exercise-based rehabilitation combined with a mitochondria-targeted antioxidant supplement called Mito-Q, or exercise-based rehabilitation with a placebo. These interventions are designed to improve vascular function by reducing oxidative stress and inflammation. The study includes a 4-year observation period with tests conducted twice annually to assess vascular health and the effectiveness of the rehabilitation approaches. Throughout the study, participants will undergo assessments of vascular endothelial function using several tests, including flow-mediated dilation, passive leg movement, and breath-hold acceleration index, at baseline and multiple follow-up times up to 4 years. Researchers will also monitor neurocognitive and pulmonary function, along with overall health risks and outcomes. The study involves regular evaluations to track progress and safety, aiming to provide clear recommendations for rehabilitation in older Veterans recovering from COVID-19 and those without COVID-19 history.
CONDITIONS
Brief Title
Long-term COVID and Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 50 years of age or greater
- Long-COVID and COVID-recovered patients must have a positive SARS-CoV-2 test near the time of COVID-19 diagnosis
- Long-COVID and COVID-recovered patients must be 3 to 12 months post-initial COVID-19 diagnosis
- Ability to sign informed consent
You will not qualify if you...
- Body mass index greater than 45 kg/m2
- Unstable (less than 6 months) or severe coronary artery disease (CAD-RADS score = 4A)
- Peripheral artery disease (Ankle Brachial Index less than 0.40)
- Cerebrovascular disease (stroke in the last 12 months)
- Severe chronic obstructive pulmonary disease (Stage III)
- Uncontrolled hypertension (greater than 160/100 mmHg)
- Chronic kidney disease requiring dialysis
- Severe renal insufficiency (creatinine clearance less than 30 by Cockcroft-Gault formula)
- Alzheimer's disease or dementia
- Orthopedic limitations preventing exercise
- Current smokers or those who stopped smoking within the last 10 years
- Currently taking Mito-Q or unwilling to stop dietary supplements for participation
- Any other condition or event considered exclusionary by the principal investigators or a physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive exercise-based rehabilitation with either Mito-Q supplementation or placebo to improve vascular endothelial function.
Visits at baseline, month 3, and month 6
Duration - Up to 4 years
Participants are assessed every 6 months for up to 4 years to evaluate long-term vascular endothelial function and health outcomes after rehabilitation.
Visits every 6 months after month 6 until year 4
Trial Site Locations
Total: 1 location
1
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah, United States, 84148-0001
Actively Recruiting
Research Team
J
Joel D Trinity, PhD
R
Russell S Richardson, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here